Most Mirvaso related news are at:

rosacea-support.org – Rosacea Support Group

Mirvaso Ingredients 27 Aug 2013 | 09:18 am

The just approved Mirvaso is a milestone in the long development and approval process. Rosacea sufferers have watched this drug since as early as 2004 when patents started emerging. Now that Mirvaso ...

Mirvaso – Frequently Asked Questions 27 Aug 2013 | 06:42 am

Surprise news today that Mirvaso, the product formerly known as Sansrosa, CD07805/47 and Col-118 has been granted approval by the FDA. Here are some of the things we already know about Mirvaso ; The...

More Mirvaso related news:

FDA approves Galderma's Mirvaso for treatment of facial redness pharmaceutical-business-review.com 27 Aug 2013 | 04:19 pm

The US Food and Drug Administration (FDA) has approved Mirvaso (brimonidine) topical gel, produced by Galderma Laboratories, for the topical treatment of the facial erythema (redness) of Rosacea in ad...

Mirvaso Ingredients rosacea-support.org 27 Aug 2013 | 09:18 am

The just approved Mirvaso is a milestone in the long development and approval process. Rosacea sufferers have watched this drug since as early as 2004 when patents started emerging. Now that Mirvaso ...

Mirvaso – Frequently Asked Questions rosacea-support.org 27 Aug 2013 | 06:42 am

Surprise news today that Mirvaso, the product formerly known as Sansrosa, CD07805/47 and Col-118 has been granted approval by the FDA. Here are some of the things we already know about Mirvaso ; The...

Mirvaso Approved for Rosacea Redness rosacea-support.org 26 Aug 2013 | 06:52 pm

News today that Galderma has succeeded in gaining FDA Approval for Mirvaso – the brand name chosen for the product that during development was known as Sansrosa, CD07805/47 and Col-118. The Brimonidi...

Sansrosa looks to be marketed as Mirvaso rosacea-support.org 16 Jul 2013 | 08:40 am

Thanks to a post from Barbara, we have learnt that a member of a German support forum for rosacea, that Galderma may be planning to market Sansrosa as Mirvaso. It is pretty brief but here is what we ...

Galderma drug is first FDA-approved facial erythema of rosacea treatment thepharmaletter.com 27 Aug 2013 | 04:21 pm

Switzerland-headquartered Galderma Laboratories says that the US Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (re...

Mirvaso Topical Gel Approved for Facial Erythema of Rosacea empr.com 26 Aug 2013 | 09:03 pm

The FDA has approved Galderma's Mirvaso (brimonidine) topical gel for the topical treatment of the facial erythema associated with rosacea in adults 18 years or older.

Galderma Receives FDA Approval of Mirvaso(R): the First and Only FDA-Approved Topical Treatment Specifically Developed and Indicated for the Facial Er... salesandmarketingnetwork.com 26 Aug 2013 | 06:08 pm

Mirvaso Works Quickly and Lasts up to 12 Hours FT. WORTH, Texas--(Healthcare Sales & Marketing Network)--Galderma Laboratories, L.P. today announced that the U.S. Food and Drug Administration (FDA) h...

Other News To Note bioworld.com 27 Aug 2013 | 09:00 am

• Galderma Laboratories LP, of Fort Worth, Texas, said the FDA approved Mirvaso (brimonidine) topical gel, for the treatment of the facial erythema (redness) of rosacea in adults 18 years of age or ol...

Mirvaso Topical Gel Approved for Facial Erythema of Rosacea oncologynurseadvisor.com 26 Aug 2013 | 09:03 pm

The FDA has approved Galderma's Mirvaso (brimonidine) topical gel for the topical treatment of the facial erythema associated with rosacea in adults 18 years or older.